Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bonecome
- Development stage
- Preclinical
- Lead developer
- MiGenTra
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Administration
- Subcutaneous
01
Overview
Bonecome is a recombinant peptide biosimilar of teriparatide, currently under development by MiGenTra for the treatment of osteoporosis. As a biosimilar of the human parathyroid hormone (PTH) fragment PTH(1-34), it functions as an anabolic agent by acting as an agonist at the parathyroid hormone 1 receptor (PTH1R). This activation stimulates osteoblast activity and bone formation, leading to increased bone mineral density and improved bone strength. Bonecome is intended to provide a therapeutic option for patients with high fracture risk or those who have failed other osteoporosis treatments. According to company pipeline information, it is in clinical development with a projected clinical project plan date of 2029.
- Brand names
- Bonecome
- Other names
- teriparatide biosimilarrecombinant human parathyroid hormone (1-34)PTH (1-34) biosimilar
Beyond the preview
Go deeper on Bonecome.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Bonecome.